LOS ALAMOS, N.M.: Observing the evolution of a particular type of antibody in an infected HIV-1 patient, a study spearheaded by Duke University, including analysis...
Washington: A small French study of 14 HIV patients who have remained healthy for years after stopping drug treatment offers fresh evidence that early medical...
Geneva:Â Twenty-five countries, many in hard-hit Africa, have at least halved new HIV infections in the past decade, with particular progress made toward protecting children...
Washington: The United States’ regulators on Monday approved Truvada, made by Gilead Sciences in California, for use as the first pill to help prevent HIV...
United Nations: A United Nation report said on Thursday that millions of HIV-affected households in Asia are facing “irreversible poverty” because of the cost of...